Followers | 827 |
Posts | 119251 |
Boards Moderated | 16 |
Alias Born | 09/05/2002 |
Monday, March 05, 2018 12:27:58 PM
http://investor.mylan.com/static-files/a8de1a59-4014-46d4-95d0-f1fccc5b24aa
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent VTRS News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 01:29:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 01:24:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 01:09:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:54:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:47:44 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:26:09 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:11:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 12:39:17 PM
- Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance • PR Newswire (US) • 02/28/2024 11:30:00 AM
- Viatris and Idorsia Enter Into Significant Global Research and Development Collaboration • PR Newswire (US) • 02/28/2024 06:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:00:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/15/2024 10:18:00 PM
- Viatris to Announce Fourth Quarter and Full-Year 2023 Financial Results • PR Newswire (US) • 02/05/2024 11:59:00 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/30/2024 09:40:59 PM
- Viatris recognised as a Top Employer 2024 in the UK for the second consecutive year • PR Newswire (US) • 01/19/2024 11:56:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 11:00:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/05/2024 01:28:15 AM
- Viatris to Participate in 42nd Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 12/21/2023 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:00:06 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/15/2023 10:04:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 10:00:53 PM
- Viatris Continues its Preparations for Phase 2 of its Strategic Plan by Announcing the Appointment of Theodora "Doretta" Mistras as Chief Financial Officer, Effective March 1, 2024, and Philippe Martin as Chief R&D Officer • PR Newswire (US) • 12/15/2023 09:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:14:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:12:00 PM
FEATURED Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market • Mar 18, 2024 8:51 AM
FEATURED Prospera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation • Mar 18, 2024 8:09 AM
Greenlite Ventures Enters into Strategic Alliance with Woodway USA • GRNL • Mar 15, 2024 4:00 PM
HealthLynked Welcomes David Rosal as New Chief Financial Officer • HLYK • Mar 13, 2024 8:00 AM
ECGI Holdings, Inc. Announces Continued Efforts in Financial Optimization • ECGI • Mar 13, 2024 8:00 AM
PSYC Begins Business Overhaul Process with Consolidation of 10 Previously Issued Convertible Debentures • PSYC • Mar 13, 2024 7:13 AM